BlackRock Fund Advisors’s Insys Therapeutics, Inc. INSY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $15.8M | Buy |
1,714,727
+162,477
| +10% | +$1.49M | ﹤0.01% | 2313 |
|
|
2016
Q3 | $18.3M | Buy |
1,552,250
+73,495
| +5% | +$867K | ﹤0.01% | 2121 |
|
|
2016
Q2 | $19.1M | Sell |
1,478,755
-20,113
| -1% | -$260K | ﹤0.01% | 2047 |
|
|
2016
Q1 | $24M | Buy |
1,498,868
+83,040
| +6% | +$1.33M | 0.01% | 1880 |
|
|
2015
Q4 | $40.5M | Sell |
1,415,828
-169,482
| -11% | -$4.85M | 0.01% | 1621 |
|
|
2015
Q3 | $45.1M | Buy |
1,585,310
+99,971
| +7% | +$2.85M | 0.01% | 1486 |
|
|
2015
Q2 | $53.4M | Buy |
1,485,339
+50,949
| +4% | +$1.83M | 0.01% | 1479 |
|
|
2015
Q1 | $41.7M | Buy |
1,434,390
+44,216
| +3% | +$1.29M | 0.01% | 1628 |
|
|
2014
Q4 | $29.3M | Buy |
1,390,174
+69,854
| +5% | +$1.47M | 0.01% | 1834 |
|
|
2014
Q3 | $25.6M | Buy |
1,320,320
+19,668
| +2% | +$381K | 0.01% | 1796 |
|
|
2014
Q2 | $20.3M | Buy |
1,300,652
+91,572
| +8% | +$1.43M | 0.01% | 2013 |
|
|
2014
Q1 | $25M | Buy |
1,209,080
+52,532
| +5% | +$1.09M | 0.01% | 1872 |
|
|
2013
Q4 | $14.9M | Buy |
1,156,548
+721,722
| +166% | +$9.31M | ﹤0.01% | 2146 |
|
|
2013
Q3 | $5.07M | Buy |
434,826
+56,241
| +15% | +$656K | ﹤0.01% | 2805 |
|
|
2013
Q2 | $1.75M | Buy |
+378,585
| New | +$1.75M | ﹤0.01% | 3118 |
|